Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Nov 1;34(31):3717-3718.
doi: 10.1200/JCO.2016.69.0040.

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer

Jonathan W Riess  1 , Primo N Lara Jr  1 , David R Gandara  1
Affiliations
Editorial

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer

Jonathan W Riess et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Riess JW, Lara PN., Jr Left behind? Drug discovery in extensive-stage small-cell lung cancer. Clin Lung Cancer. 2014;15:93–95. - PMC - PubMed
    1. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24:4539–4544. - PubMed
    1. McGranahan N, Furness AJ, Rosenthal R, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351:1463–1469. - PMC - PubMed
    1. Rizvi NA, Hellmann MD, Snyder A, et al. Cancer immunology: Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348:124–128. - PMC - PubMed
    1. Peifer M, Fernández-Cuesta L, Sos ML, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet. 2012;44:1104–1110. - PMC - PubMed

Substances